What is the appropriate workup for a patient with suspected pulmonary embolism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Suspected Pulmonary Embolism

Begin by stratifying clinical probability using a validated prediction rule (Wells or revised Geneva score), then proceed with D-dimer testing or imaging based on that probability—never order tests without first determining pretest probability. 1

Step 1: Assess Clinical Probability

Use either the Wells score or revised Geneva score to categorize patients into low, intermediate, or high probability categories before ordering any tests. 1

Wells Score Components:

  • Clinical signs/symptoms of DVT (3 points)
  • PE is most likely diagnosis (3 points)
  • Heart rate >100 bpm (1.5 points)
  • Immobilization ≥3 days or surgery within 4 weeks (1.5 points)
  • Previous PE/DVT (1.5 points)
  • Hemoptysis (1 point)
  • Malignancy (1 point) 1, 2

Interpretation:

  • Low probability: <2 points (PE prevalence ~3%)
  • Intermediate probability: 2-6 points (PE prevalence ~20-28%)
  • High probability: >6 points (PE prevalence ~36-50%) 1, 3, 2

Revised Geneva Score Components:

  • Previous PE/DVT (3 points)
  • Heart rate 75-94 bpm (3 points) or ≥95 bpm (5 points)
  • Surgery or fracture within 1 month (2 points)
  • Hemoptysis (2 points)
  • Active malignancy (2 points)
  • Unilateral leg pain (3 points)
  • Pain on deep palpation and unilateral edema (4 points)
  • Age >65 years (1 point) 4, 5, 6

Step 2: Low Probability Pathway

Apply PERC Criteria First

If the patient meets all 8 PERC criteria, PE is safely excluded without any further testing: 1, 7

  • Age <50 years
  • Heart rate <100 bpm
  • Oxygen saturation ≥95% on room air
  • No unilateral leg swelling
  • No hemoptysis
  • No recent trauma or surgery (within 4 weeks)
  • No prior history of VTE
  • No hormone use 1, 7

Critical caveat: PERC is designed only for patients <50 years old, as age <50 is one of its eight criteria. For patients ≥50 years, proceed directly to D-dimer testing. 7

If PERC Criteria Not Met

Order a high-sensitivity D-dimer (ELISA or turbidimetric assay with sensitivity ≥95%). 1

D-dimer interpretation:

  • Age ≤50 years: Use standard cutoff <500 ng/mL 1, 7
  • Age >50 years: Use age-adjusted cutoff = age × 10 ng/mL (e.g., 70 years = 700 ng/mL) 1, 7

If D-dimer is negative (below appropriate threshold): PE is excluded; no imaging needed. The 3-month thromboembolic risk is <1%. 1, 7

If D-dimer is positive: Proceed immediately to CT pulmonary angiography (CTPA). 1

Step 3: Intermediate Probability Pathway

Do not use PERC in this group. Order high-sensitivity D-dimer as the first diagnostic test. 1, 3

D-dimer interpretation:

  • Use the same age-adjusted thresholds as above 7
  • Negative D-dimer: PE excluded; no imaging required 1, 3
  • Positive D-dimer: Proceed to CTPA 1, 3

Start therapeutic anticoagulation immediately while awaiting imaging if there will be any delay in obtaining CTPA. 3, 8

Step 4: High Probability Pathway

Proceed directly to CTPA without ordering D-dimer. A negative D-dimer does not reliably exclude PE in high-probability patients and only wastes time. 1, 7

Initiate therapeutic anticoagulation before imaging confirmation. 1, 8

Step 5: Imaging Selection

CT Pulmonary Angiography (CTPA)

CTPA is the first-line imaging modality for hemodynamically stable patients. 1, 8

  • Sensitivity: ~83-95% for segmental or larger PE 1
  • Negative CTPA in low/intermediate probability patients: PE is excluded; no further testing needed 1, 8
  • Positive CTPA (segmental or more proximal filling defect): PE confirmed in intermediate/high probability patients 1, 8
  • Radiation dose: 3-10 mSv 1

Ventilation-Perfusion (V/Q) Scanning

Use V/Q scanning when CTPA is contraindicated or unavailable: 1

  • Severe contrast allergy
  • Significant renal impairment
  • Pregnancy (V/Q preferred to reduce breast radiation)
  • Hyperthyroidism 1

V/Q scan interpretation:

  • Normal perfusion scan: PE excluded 1, 8
  • High-probability scan + high clinical probability: PE confirmed 8
  • All other combinations: Require CTPA or pulmonary angiography 8
  • Radiation dose: ~2 mSv (lower than CTPA) 1

Important limitation: V/Q scanning has a ~50% inconclusive rate with planar imaging (drops to <3% with SPECT technique). 1

Lower-Extremity Compression Ultrasound

Consider before or alongside CTPA in specific circumstances: 1, 8

  • Clinical signs of DVT present
  • Renal failure or contrast allergy
  • Pregnancy (to avoid radiation if DVT confirmed)

If proximal DVT is found: This is sufficient to warrant anticoagulation without further PE imaging. 1, 8

If ultrasound is normal: Proceed to lung imaging, as ~50% of PE patients have normal leg ultrasound. 8

Step 6: Hemodynamically Unstable Patients (Massive PE)

Massive PE is defined by: Systolic BP <90 mmHg or a ≥40 mmHg drop lasting >15 minutes, or shock requiring vasopressors. 1, 8

Immediate management:

  • If patient can be transported safely: Proceed directly to CTPA 1
  • If too unstable for transport: Perform bedside echocardiography to assess RV dysfunction 1, 8
  • If RV dysfunction present on echo: This confirms high-risk PE and justifies emergency reperfusion therapy without waiting for CTPA 1, 8
  • Start unfractionated heparin (80 units/kg IV bolus, then 18 units/kg/hour infusion) immediately 1, 8

Common Pitfalls to Avoid

Never order D-dimer without first assessing clinical probability—this leads to massive overuse of imaging due to false positives. 1, 7, 8

Never order D-dimer in high-probability patients—it wastes time and resources without reliable exclusion power. 1, 7

Never use the standard 500 ng/mL D-dimer cutoff in patients >50 years—specificity drops to ~10% in patients >80 years. Use age-adjusted thresholds (age × 10 ng/mL) instead. 7

Never rely on normal oxygen saturation to exclude PE—up to 40% of PE patients have normal SaO₂. 8

Never skip imaging in high-probability patients with negative D-dimer—the negative predictive value is insufficient in this population. 1

Never use point-of-care D-dimer assays when laboratory-based tests are available—they have lower sensitivity (~88% vs ~95%). 7

Do not order CTPA as the first test in low/intermediate probability patients—D-dimer can safely exclude PE in 30-50% of such cases, avoiding unnecessary radiation and cost. 1, 3

Special Populations

Hospitalized Patients

D-dimer specificity is lower due to comorbidities (infection, cancer, inflammation, recent surgery), but sensitivity remains high. Testing remains appropriate, though the number needed to test rises from ~3 in the ED to >10 in inpatients. 7, 8

Pregnant Patients

  • V/Q scanning is preferred over CTPA to minimize breast radiation exposure 1
  • Consider lower-extremity ultrasound first to avoid any radiation if DVT can be confirmed 1
  • D-dimer has very low specificity beyond first trimester—proceed directly to imaging if intermediate/high probability 3
  • NOACs are contraindicated—use low-molecular-weight heparin or unfractionated heparin 8

Cancer Patients

Elevated baseline D-dimer lowers specificity to 18-21%, but a negative result still safely excludes PE when combined with low/intermediate clinical probability. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Intermediate Wells Score for Pulmonary Embolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Age-Adjusted D-Dimer Testing for Pulmonary Embolism Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pulmonary Embolism Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.